LU84716A1 - 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine - Google Patents

3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine Download PDF

Info

Publication number
LU84716A1
LU84716A1 LU84716A LU84716A LU84716A1 LU 84716 A1 LU84716 A1 LU 84716A1 LU 84716 A LU84716 A LU 84716A LU 84716 A LU84716 A LU 84716A LU 84716 A1 LU84716 A1 LU 84716A1
Authority
LU
Luxembourg
Prior art keywords
compound
formula
hydrogen
methyl
salt
Prior art date
Application number
LU84716A
Other languages
English (en)
French (fr)
Inventor
Aldo Antonio Algieri
Ronnie Ray Crenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU84716A1 publication Critical patent/LU84716A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU84716A 1982-03-29 1983-03-28 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine LU84716A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29
US36320782 1982-03-29

Publications (1)

Publication Number Publication Date
LU84716A1 true LU84716A1 (fr) 1983-12-05

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84716A LU84716A1 (fr) 1982-03-29 1983-03-28 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine

Country Status (30)

Country Link
JP (2) JPS58180477A (de)
KR (1) KR880002209B1 (de)
AT (1) AT386599B (de)
AU (2) AU557577B2 (de)
BE (1) BE896291A (de)
CH (2) CH655111A5 (de)
CS (2) CS250229B2 (de)
DD (2) DD210909A5 (de)
DE (1) DE3311281A1 (de)
DK (2) DK166677B1 (de)
ES (3) ES520982A0 (de)
FR (2) FR2542741B1 (de)
GB (2) GB2117769B (de)
GR (1) GR78524B (de)
HU (2) HU196386B (de)
IE (1) IE55596B1 (de)
IL (1) IL68259A0 (de)
IT (1) IT1164633B (de)
LU (1) LU84716A1 (de)
MY (1) MY8700942A (de)
NL (1) NL8301063A (de)
NO (1) NO163055C (de)
NZ (1) NZ203726A (de)
OA (1) OA07356A (de)
PT (1) PT76459B (de)
SE (2) SE461040B (de)
SU (2) SU1419518A3 (de)
YU (1) YU44849B (de)
ZA (1) ZA832154B (de)
ZW (1) ZW7683A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
EP4196793A1 (de) 2020-08-11 2023-06-21 Université de Strasbourg Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
ES8404683A1 (es) 1984-05-16
NO163055C (no) 1990-03-28
JPS58180477A (ja) 1983-10-21
ES527685A0 (es) 1985-06-16
PT76459B (en) 1986-03-11
CS250240B2 (en) 1987-04-16
HU188742B (en) 1986-05-28
GB8308518D0 (en) 1983-05-05
SE8301725L (sv) 1983-11-25
AU1290783A (en) 1983-10-06
FR2542741A1 (fr) 1984-09-21
GR78524B (de) 1984-09-27
AU586037B2 (en) 1989-06-29
ES527686A0 (es) 1985-06-16
OA07356A (fr) 1984-08-31
GB2117769A (en) 1983-10-19
JPH0568472B2 (de) 1993-09-29
DE3311281A1 (de) 1983-11-24
SU1355123A3 (ru) 1987-11-23
CS250229B2 (en) 1987-04-16
DD210909A5 (de) 1984-06-27
DK141383D0 (da) 1983-03-28
BE896291A (fr) 1983-09-28
IE830686L (en) 1983-09-29
SE8704689D0 (sv) 1987-11-25
IT1164633B (it) 1987-04-15
CH660880A5 (de) 1987-05-29
DK81192A (da) 1992-06-18
SE8301725D0 (sv) 1983-03-28
IL68259A0 (en) 1983-06-15
ATA111083A (de) 1988-02-15
IT8348005A0 (it) 1983-03-28
ES520982A0 (es) 1984-05-16
ES8505977A1 (es) 1985-06-16
DK81192D0 (da) 1992-06-18
GB2117769B (en) 1985-08-29
NO163055B (no) 1989-12-18
SU1419518A3 (ru) 1988-08-23
SE8704689L (sv) 1987-11-25
AU557577B2 (en) 1986-12-24
AT386599B (de) 1988-09-12
GB8432809D0 (en) 1985-02-06
SE461040B (sv) 1989-12-18
SE464302B (sv) 1991-04-08
CH655111A5 (de) 1986-03-27
FR2542741B1 (fr) 1989-12-08
DK141383A (da) 1983-09-30
JPH06135925A (ja) 1994-05-17
IE55596B1 (en) 1990-11-21
YU74483A (en) 1986-02-28
PT76459A (en) 1983-04-01
AU6327286A (en) 1987-01-08
KR880002209B1 (ko) 1988-10-18
DD219768A5 (de) 1985-03-13
ZA832154B (en) 1983-12-28
HU196386B (en) 1988-11-28
YU44849B (en) 1991-04-30
ES8505978A1 (es) 1985-06-16
ZW7683A1 (en) 1984-01-04
FR2597867B1 (fr) 1989-12-08
NL8301063A (nl) 1983-10-17
MY8700942A (en) 1987-12-31
NZ203726A (en) 1986-05-09
FR2597867A1 (fr) 1987-10-30
GB2149406B (en) 1986-01-02
GB2149406A (en) 1985-06-12
KR840004095A (ko) 1984-10-06
NO831100L (no) 1983-09-30
DK166677B1 (da) 1993-06-28

Similar Documents

Publication Publication Date Title
EP0487408B1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen
HU229356B1 (en) Process for the crystallization of (r)- or (s)-lansoprazole
LU84157A1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones,leur procede de preparation et composition pharmaceutique les contenant
FR2488890A1 (fr) Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques
LU84716A1 (fr) 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine
FR2477150A1 (fr) Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant
FI69069B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-yan-n'-(2-((4-metyl-5-imidazolyl)metyltio)etyl)-n"-alkyny lganidiner
US4528375A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FR2565980A1 (fr) Nouveaux esters de 1,1-dioxydes de n-heteroaryl-4-hydroxy-2-methyl- 2h -1,2-benzothiazine- (ou thieno(2,3-e)-1,2-thiazine)-3-carboxamide precurseurs de medicaments et composition pharmaceutiques les contenant
CA1100968A (fr) Procedes de preparation de nouvelles piperazines disubstituees
CH644858A5 (fr) Derives du (pyridyl-2)-2 tetrahydrothiophene, leur preparation et les medicaments qui les contiennent.
US4528377A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
CA1250847A (fr) Preparation de thieno et furo-¬2,3-c| pyrroles
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) Ethanediimidamide intermediates
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
FR2499991A1 (fr) Nouveaux 2,1,3-benzothiadiazoles et 2,1,3-benzoxadiazoles, leur preparation et leur application comme medicaments
KR100382998B1 (ko) 6-메톡시-1h-벤조트리아졸-5-카르복사미드유도체,그제조방법및그것을함유하는의약조성물
US4517366A (en) Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4595758A (en) Ethanediimidamide intermediates
EP0280627B1 (de) N-substituierte alpha-Mercaptomethylbenzenpropanamid-Derivate, ihre Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zusammensetzungen
BE895076R (fr) 1-oxydes et 1, 1-dioxydes de 1,2,5-thiadiazoles 3,4-disubstitues
FR2487351A1 (de)
KR790001525B1 (ko) 치환된 인돌유도체의 제법